Display options
Cite
Tsering DC, Das S, Adhiakari L, et al. Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial Origin. J Glob Infect Dis. 2009;1(2):87-92doi: 10.4103/0974-777X.56247.
Tsering, D. C., Das, S., Adhiakari, L., Pal, R., & Singh, T. S. (2009). Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial Origin. Journal of global infectious diseases, 1(2), 87-92. https://doi.org/10.4103/0974-777X.56247
Tsering, Dechen C, et al. "Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial Origin." Journal of global infectious diseases vol. 1,2 (2009): 87-92. doi: https://doi.org/10.4103/0974-777X.56247
Tsering DC, Das S, Adhiakari L, Pal R, Singh TS. Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial Origin. J Glob Infect Dis. 2009 Jul;1(2):87-92. doi: 10.4103/0974-777X.56247. PMID: 20300397; PMCID: PMC2840957.
Copy Download .nbib Format: NLM
Share it on

J Glob Infect Dis. 2009 Jul;1(2):87-92. doi: 10.4103/0974-777X.56247.

Extended Spectrum Beta-lactamase Detection in Gram-negative Bacilli of Nosocomial Origin.

Journal of global infectious diseases

Dechen C Tsering, Shyamasree Das, Luna Adhiakari, Ranabir Pal, Takhellambam Sk Singh

Affiliations

  1. Department of Microbiology, Sikkim-Manipal Institute of Medical Sciences(SMIMS) and Central Referral Hospital (CRH), Gangtok, Sikkim, India.

PMID: 20300397 PMCID: PMC2840957 DOI: 10.4103/0974-777X.56247

Abstract

BACKGROUND: Resistance to third generation cephalosporins by acquisition and expression of extended spectrum beta lactamase (ESBL) enzymes among gram-negative bacilli is on a rise. The presence of ESBL producing organisms significantly affects the course and outcome of an infection and poses a challenge to infection management worldwide.

MATERIALS AND METHODS: In the period from June 2007 to 2008, we collected 1489 samples from patients suspected of nosocomial infection. The isolates were identified based on colony morphology and biochemical reaction. Gram negative bacilli resistant to third generation cephalosporins were tested for ESBL by double disc synergy test (DDST- a screening test)and then phenotypic confirmatory test. Antimicrobial susceptibility testing was done by modified Kirby Bauer disc diffusion method.

RESULTS: From the sample of 238 gram-negative bacilli, we isolated Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Citrobacter freundii, Proteus mirabilis, Morganella morganii and Enterobacter cloacae. Following both methods, 34% isolates were ESBL-positive. The ESBL producing isolates were significantly resistant (p < 0.01) to ampicillin, piperacillin, piperacillin/tazobactam, trimethoprim/sulfamethoxazole, tetracycline, ciprofloxacin and gentamicin as compared to non-ESBL producers. Multidrug resistance was significantly (p < 0.01) higher (69.14%) in ESBL positive isolates than non-ESBL isolates (21.66%).

CONCLUSION: High prevalence of ESBL in our hospital cannot be ignored. ESBL producers can be detected by DDST and phenotypic confirmatory test with equal efficacy. The sensitivity of screening test improved with the use of more than one antibiotic and addition of one or two antibiotics would not increase cost and labor. We recommend DDST using multiple antibiotics in all microbiology units as a routine screening test.

Keywords: ESBL; Gram negative bacilli; Nosocomial

References

  1. J Clin Microbiol. 1997 Oct;35(10):2593-7 - PubMed
  2. J Antimicrob Chemother. 2000 Feb;45(2):183-9 - PubMed
  3. J Infect. 2003 Nov;47(4):273-95 - PubMed
  4. J Clin Microbiol. 2001 Jun;39(6):2206-12 - PubMed
  5. Indian J Pathol Microbiol. 2005 Jan;48(1):45-8 - PubMed
  6. J Antimicrob Chemother. 2002 Jan;49(1):169-72 - PubMed
  7. Indian J Med Res. 1995 Aug;102:53-5 - PubMed
  8. J Antimicrob Chemother. 1994 Mar;33(3):666-8 - PubMed
  9. Indian J Med Res. 2004 Dec;120(6):553-6 - PubMed
  10. JAMA. 1999 Jan 6;281(1):67-71 - PubMed
  11. J Clin Microbiol. 1996 Aug;34(8):1880-4 - PubMed
  12. Jpn J Infect Dis. 2004 Aug;57(4):146-9 - PubMed
  13. Chin Med J (Engl). 2002 Oct;115(10):1479-82 - PubMed
  14. Antimicrob Agents Chemother. 1992 Sep;36(9):1877-82 - PubMed
  15. J Antimicrob Chemother. 1999 Mar;43(3):373-8 - PubMed
  16. Am J Infect Control. 2007 Dec;35(10 Suppl 2):S165-93 - PubMed
  17. Med Sci Monit. 2002 Jan;8(1):CR44-7 - PubMed
  18. Indian J Med Res. 2005 Nov;122(5):425-8 - PubMed
  19. Indian J Med Microbiol. 2002 Apr-Jun;20(2):92-5 - PubMed
  20. Antimicrob Agents Chemother. 2002 Dec;46(12):3837-42 - PubMed
  21. Indian J Med Res. 1997 Apr;105:158-61 - PubMed
  22. Lancet. 1998 Mar 14;351(9105):797-9 - PubMed
  23. J Chemother. 1995 Dec;7(6):509-14 - PubMed
  24. Emerg Infect Dis. 2001 Mar-Apr;7(2):333-6 - PubMed
  25. Clin Microbiol Rev. 2001 Oct;14(4):933-51, table of contents - PubMed
  26. Clin Microbiol Rev. 2005 Oct;18(4):657-86 - PubMed
  27. Indian J Med Microbiol. 2004 Jul-Sep;22(3):172-4 - PubMed
  28. Rev Infect Dis. 1988 Jul-Aug;10(4):867-78 - PubMed
  29. J Clin Microbiol. 1997 Aug;35(8):2061-7 - PubMed

Publication Types